Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00237679 · ClinicalTrials.gov registry record · NA

Quantifying Effects of Treatment of Pediatric Dysphonia

A NA study, sponsored by University of Wisconsin, Madison.

Terminated
Registry status
NA
Development phase
31
Enrollment target

NCT00237679: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.

NCT00237679 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00237679, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.

TERMINATED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

The diagnosis and management of childhood dysphonia is a significant clinical problem; however, there have been few studies aimed at defining standard assessment methods for pediatric dysphonia. Accordingly, pediatric dysphonia is difficult to diagnose and it is difficult to quantify change following treatment. The long-term goal of this research program is to develop valid, responsive, reliable, and age-appropriate methods for assessing vocal pathology in children. In the present small grant, our objective is to define assessment methods that are appropriate for use in determining response to treatment. Our main focus, therefore, is the issue of assessment responsivity. The first specific aim is to develop a set of responsive measures of vocal pathology in school-aged children by inducing short-term change in vocal status via behavioral and medical management of extraesophageal reflux disease (EERD). Because we are treating children suspected of EERD, this study also presents the opportunity for examining the benefits of combined vocal hygiene and medical management in the treatment of pediatric EERD. Accordingly, our second specific aim is to determine predictive criteria for improvement in vocal status in dysphonic children suspected of EERD. Our hypothesis is that a particular set of measurements will emerge as particularly responsive to change in vocal pathology in this population, and will allow for informed prediction of degree of improvement with treatment. The proposed research is significant in filling a gap in knowledge in childhood dysphonia assessment and treatment, which are important clinical issues consistent with the mission and intent of the NIDCD. Because phonatory disorders in children may have lasting negative effects, studies geared toward accurate assessment and treatment are very important.

Primary Outcome

Determine the effectiveness of medical treatment for hypopharyngeal EERD in dysphonic children.

Interventions

  • BEHAVIORAL Neuromuscular Electrical Stimulation
  • BEHAVIORAL Unstimulated

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2004-01
Est. Completion 2008-12
Phase NA
University of Wisconsin, Madison

1,039 total trials

Why NCT00237679 stopped before completion

NCT00237679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Neuromuscular Electrical Stimulation is the first listed.

NCT00237679 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00237679 about?

NCT00237679 is a clinical study titled "Quantifying Effects of Treatment of Pediatric Dysphonia". The diagnosis and management of childhood dysphonia is a significant clinical problem; however, there have been few studies aimed at defining standard assessment methods for pediatric dysphonia. Accordingly, pediatric dysphonia is difficult to diagnose and it is difficult to quantify change followin...

What is the current status of trial NCT00237679?

This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2004-01. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00237679?

The interventions under investigation include: Neuromuscular Electrical Stimulation (BEHAVIORAL), Unstimulated (BEHAVIORAL).

Who is sponsoring clinical trial NCT00237679?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00237679's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00237679, the US trial registry maintained by the National Library of Medicine. NCT00237679 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.